Effects of Coronary Artery Revascularization with a Polymer-Free Biolimus A9-Coated BioFreedom Stent Versus Bypass Surgery before Noncardiac Surgery.

CONCLUSION: This study demonstrated that BioFreedom stenting as a revascularization strategy before major noncardiac surgery might be feasible and safe in selected patients with less severe coronary artery diseases.
PMID: 29749130 [PubMed - in process]

Source: Yonsei Medical Journal - May 13, 2018 Category: Universities & Medical Training Authors: Kim K, Kim C, Kim BK, Jang JY, Her AY, Kim S, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y Tags: Yonsei Med J Source Type: research